Clinical Data Plans 3-for-2 Stock Split to Thump Chest, Draft New Investors | GenomeWeb
NEW YORK (GenomeWeb News) — Clinical Data last week said that its board has authorized a 3-for-2 stock split, which will be effected in the form of a stock dividend.
On Oct. 1, stockholders of record as on Sept. 24 will receive one new share for every two shares they hold, the company said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.